PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 91 filers reported holding PASSAGE BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -73.1% | 2,961 | -64.1% | 0.00% | – |
| Q1 2022 | $26,000 | -50.9% | 8,255 | 0.0% | 0.00% | – |
| Q4 2021 | $53,000 | -35.4% | 8,255 | 0.0% | 0.00% | – |
| Q3 2021 | $82,000 | +74.5% | 8,255 | +132.6% | 0.00% | – |
| Q2 2021 | $47,000 | -30.9% | 3,549 | -9.7% | 0.00% | – |
| Q1 2021 | $68,000 | -16.0% | 3,932 | +24.1% | 0.00% | – |
| Q4 2020 | $81,000 | +189.3% | 3,168 | +51.0% | 0.00% | – |
| Q3 2020 | $28,000 | -61.1% | 2,098 | -20.2% | 0.00% | – |
| Q2 2020 | $72,000 | – | 2,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |